Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Verrica Pharmaceuticals (1NE0) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Vp-102 / To-208, Vehicle / VehicleWarts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingCantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)May 27, 2026
CantharidinWarts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingLong-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)Feb 24, 2026―
Vehicle, Vp-102Warts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingCantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)Nov 17, 2025
Part 1: Vp-315 3 Day Dosing/Week, Part 2: Vp-315 3 Day Dosing/Week - Loading Dose, Part 2: Vp-315 2 Day Dosing/Week - Split Dose, Part 2: Vp-315 3 Day Dosing/Week - Split DoseBasal Cell Carcinoma, Skin Cancer, Carcinoma, Cancer Of The Skin, Basal Cell, Cancer Of The SkinPhase IICompletedOpen-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaDec 13, 2021―
Vp-102 And ApplicatorSkin Diseases, Papillomavirus Infections, Warts, Sexually Transmitted Diseases, Skin Diseases, Viral, Skin Diseases, Infectious, Condylomata Acuminata, Sexually Transmitted Diseases, ViralPhase IICompletedA Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsJun 06, 2019―
Vp-102 Cantharidin Topical Film Forming SolutionSkin Diseases, Virus Diseases, Papillomavirus Infections, Warts, Warts Hand, Verruca, Common Wart, Dna Virus Infections, Skin Diseases, Viral, Skin Diseases, Infectious, Tumor Virus Infections, Verruca VulgarisPhase IICompletedCantharidin and Occlusion in Verruca EpitheliumMar 21, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Verrica Pharmaceuticals (DE:1NE0) have in its pipeline
Verrica Pharmaceuticals DE:1NE0 is currently developing the following drugs: Vp-102 / To-208, Vehicle / Vehicle, Cantharidin, Vehicle, Vp-102, Part 1: Vp-315 3 Day Dosing/Week, Part 2: Vp-315 3 Day Dosing/Week - Loading Dose, Part 2: Vp-315 2 Day Dosing/Week - Split Dose, Part 2: Vp-315 3 Day Dosing/Week - Split Dose, Vp-102 And Applicator, Vp-102 Cantharidin Topical Film Forming Solution. These drug candidates are in various stages of clinical development as the company works toward FDA approval.